Bullpen.News · the best place to find stock ideas

Atour Lifestyle ($ATAT): The Hotel Chain That Is Secretly a (Sleep) DTC E-Commerce Brand

Atour Lifestyle combines an asset-light Chinese hotel franchise network with Atour Planet sleep-product sales, using guest rooms as product showrooms.

ATAT $4.5B

Substack von Philipp 25m ago

3h ago SE $57B

Sea Limited (SE) Sea Cloud and Monee IPO

Sleep Well Investments 2 clicks

6h ago META $1.8T

Meta 3Q26 Business Update: Not Just an Ads Business?

Speedwell Research 6 clicks

From X

@AsifSuria Aug 29

Asif Suria on X

@yenoms Unfortunately I have not tracked the preferreds to have an informed opinion. Last preferred I bought was $LILAP when it dipped to the mid-$19 level. There was a cluster of insider purchases of that preferred including by Malone.

@negligible_cap Aug 29

Negligible Capital on X

How many $META users do they really see being willing and/or able to pay $200 per month for Hatch? I’m pretty good at ordering Doordash and scrolling Reddit on my own thank you very much https://t.co/2Oyf2hoyw4

@ChrisCamillo Aug 29

Chris Camillo on X

Well, that escalated quickly. $TTWO https://t.co/J56bmG6WiS

@irbezek Aug 29

Ian Bezek on X

$TEAM was at $56 just a few months ago, such efficient markets. Reminder, people only care about SBC when stonk prices are going down. Beware folks fitting a narrative onto price action. https://t.co/FaPZr8c7dn

@AsifSuria Aug 29

Asif Suria on X

It takes courage to go against the current looking for opportunities that the market will not reward in the short-term. Times of turmoil is when we pay special attention to insiders and they led us to energy stock in mid-2020, regional banks in H1 2023, biotech companies in early 2025 and more recently SaaS stocks. While I don't have a position in $NOW, we did start positions in $CRM, $NAVN (partially exited) and more. Here is some of what I wrote about that decision to double down on SaaS in our July 2026 newsletter:

@TidefallCapital Aug 28

Trevor Scott on X

@DrewCohenMoney enjoyed your $APP video

@ChrisCamillo Aug 28

Chris Camillo on X

@PostmodernRogue @fkon1u @DumbMoneyTV what exactly do you think is priced in? >37M launch-quarter units? >45M? >50M? what ARPU? “priced in” isn’t an argument without numbers. There is upside and downside. Been crushing $TTWO GTA trades since ’99. Always happy to compare notes.

@partners_road Aug 28

RiverRoadPartners on X

Why does he think hedge fund analysts “missed” $NVDA? Every fund I know has been long for some part of the last 5+ years. Did he think it became the most valuable stock in the world from just him (the only hedge fund to own it) and mutual funds? Bull market genius. https://t.co/mS6HJQX61L

Free Recaps of the best new stock ideas, delivered every morning.

Read past recaps

Bumble is being taken private

Bumble agreed to a $6.05-per-share cash sale to Ithaca Holdings, 136% above its October 2 share price.

BMBL $783M

Modern Value Investing 13h ago 6 clicks

GLOO, part two

Gloo faces related-party deals, insider-heavy IPO ownership, acquisition losses and $84.5 million of CEO-backed puts as it burns cash and…

GLOO $291M

Guardian Research 14h ago 2 clicks

Netflix Q3 Earnings Update

Netflix Q3 earnings update revises the thesis and rating.

NFLX $511B

Rebound Capital 19h ago 11 clicks

Sagimet Biosciences: The U.S. Acne Trial Is A Replication Exercise, Not A Discovery Bet

Sagimet Biosciences' denifanstat enters a fully funded U.S. acne registration trial after Phase 3 results, with SGMT trading below cash and…

SGMT $695M

Equity Eagle 20h ago 1 click

CoreWeave: It’s Not Dying, Not Anytime Soon

CoreWeave is compared with Amazon's early public years, when investors expected bankruptcy amid losses and dependence on outside capital.

CRWV $34B

Capitalist Letters 20h ago 17 clicks

Eli Lilly And Co. (LLY)

Eli Lilly's Mounjaro and Zepbound drove 2025 revenue to $65.2 billion as the drugmaker expands AI partnerships with Nvidia, Isomorphic…

LLY $1.2T

SixSigmaCapital: Navigating the Financial Markets 21h ago 11 clicks

Gladstone Investment: High Dividend Increases And NAV Gains, But Very Risky

Gladstone Investment's 50% equity portfolio drove NAV and dividend gains, but five holdings make up 44.5% of fair value and heighten Level…

GAIN $588M

Stephen Nemo 25h ago 2 clicks

Why I sold OB pick for 26 SVM

Silvercorp’s falling Ying grades, prolonged GC suspension, El Domo execution risk and Chaarat funding needs weaken its valuation despite…

SVM $2B

The Oak Bloke 27h ago 16 clicks

ServiceNow: The Shift From Seats To 'Assists' Uncaps Exponential Growth

ServiceNow is shifting from seat-based subscriptions to usage-based AI “Assists,” expanding revenue potential across its enterprise…

NOW $152B

Raul Shah 28h ago 2 clicks

Use of AI is boosting Snowflake’s revenue while mortal companies may take longer

Snowflake says internal AI use is lifting revenue and profit, while customers show early implementation success.

SNOW $111B

The Technology Letter 32h ago 5 clicks

Netflix Earnings, Business or Franchise, Disney’s Deal

Netflix’s earnings raise questions about whether its growth profile still merits a franchise valuation, alongside discussion of Disney’s…

NFLX $511BDIS $193B

Stratechery by Ben Thompson – On the business, strategy, and impact of technology. 32h ago 3 clicks

Vicor Update, Part Three

Vicor’s $66.6 million in AI power-delivery royalties generated about $50 million of operating profit, eclipsing its module business as…

VICR $9.7B

CV's Substack 34h ago 28 clicks

Inogen: Cheap Enough To Take A Chance On

Inogen's $45 million buyback, debt-free balance sheet and cash equal to 61% of market value support a Buy case despite 3% 2026 growth…

INGN $166M

Intrinsic Analysis 35h ago 7 clicks

Carecloud News

CareCloud may attract a private-equity buyer after its Q3 call, with acquiring enough shares the main obstacle to a take-private deal.

CCLD $79M

Calvin Blissett 35h ago 10 clicks

From Fat to Follicles - Is Hair Loss the Next Blockbuster?

Novo Nordisk has only floated hair loss, while Veradermics’ Phase 3 oral minoxidil data lead a field of licensing and takeover candidates.

NVO $172BMANE $5.3B

Cestrian Capital Research 37h ago 40 clicks

Is Microsoft Over-Earning on OpenAI?

Microsoft booked $24.1 billion from OpenAI in FY2026, nearly a quarter of Azure revenue, raising questions over finite, high-margin…

MSFT $4T

MBI Deep Dives 40h ago 21 clicks

RTX Corporation (NYSE: RTX) Q3 FY12/26 Earnings Update - Accumulate, Record $340bn Backlog, Zones And Stop Inside

RTX reported 11% sales growth to $25.0 billion, raised 2026 guidance and reached a record $340 billion backlog, while free cash flow fell…

RTX $259B

Cestrian Capital Research 41h ago 9 clicks

Heico Corporation

HEICO sells FAA-approved aircraft replacement parts at 30% to 50% discounts to OEMs, gaining customers as restrictive aftermarket contracts…

HEI $42B

D Invests 43h ago 13 clicks

Northrop Grumman (NYSE: NOC) Q3 FY12/26 Earnings Update - Accumulate, Record Backlog, Zones And Stop Inside

Northrop Grumman posted 7% Q3 sales growth to $11.1 billion, lifted profit guidance and reached a record $109.6 billion backlog, led by…

NOC $73B

Cestrian Capital Research 43h ago 4 clicks

Disney: Century-Old Franchises at 14x Forward Earnings

Disney trades at 14x FY27 consensus EPS of $7.50 as parks, merchandise and streaming rebuild its franchise flywheel.

DIS $193B

Latticework by MOI Global 44h ago 10 clicks

Latest News

Asif Suria on X

Negligible Capital on X

Chris Camillo on X

Ian Bezek on X

Asif Suria on X

Trevor Scott on X

Chris Camillo on X

RiverRoadPartners on X

Investor Letters

Recent recaps

Latest recap

Publications we follow

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 54 of 245

X accounts we follow

Investor letters we follow

Sectors